Nevada § 422.27235 - State Plan for Medicaid: Inclusion of requirement for payment of certain costs related to testing for, preventing or treating of human immunodeficiency virus or hepatitis C

§ 422.27235. State Plan for Medicaid: Inclusion of requirement for payment of certain costs related to testing for, preventing or treating of human immunodeficiency virus or hepatitis C

1. The Director shall include in the State Plan for Medicaid a requirement that the

State pay the nonfederal share of expenditures incurred for: (a) Any laboratory testing that is necessary for therapy that uses a drug approved

by the United States Food and Drug Administration for preventing the acquisition of

human immunodeficiency virus. (b) The services of a pharmacist described in NRS 639.28085 . The State must provide reimbursement for such services at a rate equal to the rate

of reimbursement provided to a physician, physician assistant or advanced practice

registered nurse for similar services. (c) Any service to test for, prevent or treat human immunodeficiency virus or hepatitis

C provided by a provider of primary care if the service is covered when provided by

a specialist and: (1) The service is within the scope of practice of the provider of primary care;

or (2) The provider of primary care is capable of providing the service safely and effectively

in consultation with a specialist and the provider engages in such consultation. 2. The Director shall include in the State Plan for Medicaid a requirement that the

State reimburse an advanced practice registered nurse or a physician assistant for

any service to test for, prevent or treat human immunodeficiency virus or hepatitis

C at a rate equal to the rate of reimbursement provided to a physician for similar

services. 3. As used in this section, “ primary care ” means the practice of family medicine, pediatrics, internal medicine, obstetrics

and gynecology and midwifery.